Michael McDonell, PhD

Personal Statement

My primary interest is on determining how behavioral technologies can be used to improve alcohol and drug abuse outcomes for those suffering from addiction health disparities. Behavioral technologies are non-talk therapy approaches to addiction treatment, such as motivational incentives where we provide rewards for people who abstain from or reduce their drinking. This low-cost, strength based approach to addiciton can be implimented in low-resources settings by non clinicians. In fact, our group is investigating how smartphones might be used to impliment this treatment, allowing us to reach the millions of individuals suffering from alcohol problems worldwide.  

My second research interest in evaluating the accuracy of alcohol biomarkers in addiction treatment settings. These include alcohol urine tests, such as ethyl glucuronide (EtG) and mobile phone linked Bluetooth breathalyzers. These tools allow us to accurately assess  the sucess of alcohol treatments, as well as provide valuable research tools.      

Importantly all of my ressearch studies are conducted in collaboration with two communities that suffer dispproporationately high rates of alcohol and drug miuse, 1) adults with severe mental illnesses, like schizophrenia and bipolar disorder and 2) American Indians and Alaska Natives. My reserach team and I work closely with community partners who are providing addiction treatment to these populations with the goal of reducing the burden of alcohol and drug use in these communities. 

Recent Publications

Cannabis use and metabolic syndrome among clients with first episode psychosis.
(2020 Sep 2)
Early Interv Psychiatry
Stiles E, Alcover KC, Stiles B, Oluwoye O, McDonell MG

Family Experiences Prior to the Initiation of Care for First-Episode Psychosis: A Meta-Synthesis of Qualitative Studies.
(2020 Sep)
J Child Fam Stud 29(9): 2530-2541
Oluwoye O, Cheng SC, Fraser E, Stokes B, McDonell MG

Developing and implementing a culturally informed FAmily Motivational Engagement Strategy (FAMES) to increase family engagement in first episode psychosis programs: mixed methods pilot study protocol.
(2020 Aug 26)
BMJ Open 10(8): e036907
Oluwoye O, Dyck D, McPherson SM, Lewis-Fernández R, Compton MT, McDonell MG, Cabassa LJ

Understanding differences in family engagement and provider outreach in New Journeys: A coordinated specialty care program for first episode psychosis.
(2020 Sep)
Psychiatry Res 291(): 113286
Oluwoye O, Stokes B, Stiles B, Monroe-DeVita M, McDonell MG

Assessing the Predictive Validity of the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) in Alaska Native and American Indian People.
(2020 Sep/Oct)
J Addict Med 14(5): e241-e246
Lillie KM, Jansen KJ, Dirks LG, Lyons AJ, Alcover KC, Avey JP, Hirchak K, Herron J, Buchwald D, Donovan DM, McDonell MG, Shaw JL

Show complete publication list »